日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

High Mobility Group Box 1 Is Potential Target Therapy for Inhibiting Metastasis and Enhancing Drug Sensitivity of Hepatocellular Carcinoma

高迁移率族蛋白B1是抑制肝细胞癌转移和增强其药物敏感性的潜在靶点治疗药物

Jiraviriyakul, Arunya; Nensat, Chatchai; Promchai, Samitanan; Chaiaun, Yanisa; Hoiraya, Yanisa; Yamnak, Nutnicha; Khutanthong, Suphakit; Singpan, Nun; Songjang, Worawat

Higher expression of high-mobility group box 1 in cholangiocarcinoma and association with cell growth, in vitro migration and invasion, and chemo-drug sensitivity

胆管癌中高迁移率族蛋白1(HMGB1)的高表达与细胞生长、体外迁移和侵袭以及化疗药物敏感性相关。

Jiraviriyakul, Arunya; Promchai, Samitanan; Nensat, Chatchai; Khutanthong, Suphakit; Singpan, Nun; Songjang, Worawat

Risk of circulatory diseases associated with proton-pump inhibitors: a retrospective cohort study using electronic medical records in Thailand

质子泵抑制剂相关循环系统疾病风险:一项基于泰国电子病历的回顾性队列研究

Pannoi, Tanavij; Promchai, Chissanupong; Apiromruck, Penjamaporn; Wongpraphairot, Suwikran; Dong, Yaa-Hui; Yang, Chen-Chang; Pan, Wen-Chi

Multi-label classification of symptom terms from free-text bilingual adverse drug reaction reports using natural language processing

利用自然语言处理技术对自由文本双语药物不良反应报告中的症状术语进行多标签分类

Chaichulee, Sitthichok; Promchai, Chissanupong; Kaewkomon, Tanyamai; Kongkamol, Chanon; Ingviya, Thammasin; Sangsupawanich, Pasuree

Estimates of Chronic Kidney Diseases Associated with Proton-Pump Inhibitors Using a Retrospective Hospital-Based Cohort in Thailand

泰国一项基于医院回顾性队列研究对质子泵抑制剂相关慢性肾脏病的发生率进行了评估

Pannoi, Tanavij; Promchai, Chissanupong; Apiromruck, Penjamaporn; Wongpraphairot, Suwikran; Yang, Chen-Chang; Pan, Wen-Chi